Emerald Mutual Fund Advisers Trust Sells 2,753 Shares of Integer Holdings Corporation (NYSE:ITGR)

Emerald Mutual Fund Advisers Trust cut its holdings in shares of Integer Holdings Corporation (NYSE:ITGR - Free Report) by 13.9% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 17,114 shares of the medical equipment provider's stock after selling 2,753 shares during the quarter. Emerald Mutual Fund Advisers Trust's holdings in Integer were worth $2,020,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Charles Schwab Investment Management Inc. increased its position in Integer by 1.1% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 408,588 shares of the medical equipment provider's stock worth $54,146,000 after buying an additional 4,559 shares during the last quarter. Proficio Capital Partners LLC bought a new stake in shares of Integer during the 4th quarter worth about $2,195,000. Amundi increased its holdings in shares of Integer by 194.3% during the 4th quarter. Amundi now owns 17,372 shares of the medical equipment provider's stock valued at $2,313,000 after acquiring an additional 11,469 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Integer by 3.1% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,904 shares of the medical equipment provider's stock valued at $782,000 after acquiring an additional 180 shares in the last quarter. Finally, Wealthfront Advisers LLC bought a new position in shares of Integer in the 4th quarter valued at approximately $4,754,000. Hedge funds and other institutional investors own 99.29% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. KeyCorp decreased their price target on shares of Integer from $154.00 to $145.00 and set an "overweight" rating for the company in a report on Monday, April 21st. Raymond James Financial increased their target price on Integer from $145.00 to $150.00 and gave the company an "outperform" rating in a research note on Friday, April 25th. Benchmark dropped their price target on Integer from $150.00 to $140.00 and set a "buy" rating on the stock in a research report on Friday, April 25th. Truist Financial set a $150.00 price target on Integer and gave the stock a "buy" rating in a report on Friday, April 25th. Finally, Wall Street Zen upgraded shares of Integer from a "sell" rating to a "hold" rating in a research note on Monday, May 19th. Two research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, Integer currently has an average rating of "Moderate Buy" and a consensus price target of $145.00.

Insiders Place Their Bets

In other news, CEO Joseph W. Dziedzic sold 338,975 shares of the stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $123.17, for a total transaction of $41,751,550.75. Following the completion of the transaction, the chief executive officer directly owned 47,000 shares in the company, valued at $5,788,990. This represents a 87.82% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Donald J. Spence sold 14,739 shares of the stock in a transaction that occurred on Wednesday, June 4th. The shares were sold at an average price of $120.38, for a total value of $1,774,280.82. Following the completion of the sale, the director directly owned 18,781 shares of the company's stock, valued at approximately $2,260,856.78. The trade was a 43.97% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 362,434 shares of company stock valued at $44,577,115 in the last quarter. 2.16% of the stock is currently owned by insiders.

Integer Trading Down 1.7%

Integer stock traded down $2.04 during mid-day trading on Friday, hitting $119.73. 343,094 shares of the company's stock were exchanged, compared to its average volume of 388,549. Integer Holdings Corporation has a fifty-two week low of $104.93 and a fifty-two week high of $146.36. The company's 50 day simple moving average is $119.85 and its 200-day simple moving average is $125.07. The firm has a market capitalization of $4.18 billion, a P/E ratio of 56.74, a PEG ratio of 1.05 and a beta of 0.98. The company has a quick ratio of 2.14, a current ratio of 3.40 and a debt-to-equity ratio of 0.78.

Integer (NYSE:ITGR - Get Free Report) last posted its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.27 by $0.04. The business had revenue of $437.39 million during the quarter, compared to analysts' expectations of $428.51 million. Integer had a return on equity of 11.95% and a net margin of 4.38%. Integer's revenue for the quarter was up 7.3% compared to the same quarter last year. During the same period in the prior year, the business earned $1.14 EPS. On average, equities analysts anticipate that Integer Holdings Corporation will post 6.01 earnings per share for the current year.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.